Effect of Food on Pharmacokinetics of MY008211A Tablets in Healthy Adult Subjects

Summary

This was a single-center, single-dose, open-label clinical study. 12 subjects were randomly assigned in a 1:1 ratio to one of the following dosing sequences (sequence 1: AB; Sequence 2: BA). Each dosing sequence consisted of two cycles, one dose per cycle, with a 5-day washout period between doses.

Timeline

Start

2022-09-26

Primary completion

2022-10-23

Completion

2022-10-23

Drugs

Indications